ROBERT CAIVANO: Open Payments
NPI 1891107561 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 84 payments from 18 companies in 2025. Trend: 2023 $1,424 · 2024 $1,446 · 2025 $1,296
Food & beverage: $1,296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $237 |
| PFIZER INC. | 18 | $137 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| ABBVIE INC. | 7 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $117 |
| Lilly USA, LLC | 6 | $110 |
| Astellas Pharma US Inc | 4 | $60 |
| Dexcom, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Exact Sciences Corporation | 3 | $47 |
Products named: TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, Ozempic, VRAYLAR, NURTEC ODT, Wegovy, Veozah.
Industry payments across TX — which companies pay providers there.
